BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 19283971)

  • 1. Comorbidity and "self-medication".
    DuPont RL; Gold MS
    J Addict Dis; 2007; 26 Suppl 1():13-23. PubMed ID: 19283971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on Alcohol and Related Conditions.
    Bolton JM; Robinson J; Sareen J
    J Affect Disord; 2009 Jun; 115(3):367-75. PubMed ID: 19004504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major depression and comorbid substance use disorders.
    Davis L; Uezato A; Newell JM; Frazier E
    Curr Opin Psychiatry; 2008 Jan; 21(1):14-8. PubMed ID: 18281835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comorbid alcohol and substance abuse dependence in depression: impact on the outcome of antidepressant treatment.
    Ostacher MJ
    Psychiatr Clin North Am; 2007 Mar; 30(1):69-76. PubMed ID: 17362804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-medication of anxiety disorders with alcohol and drugs: Results from a nationally representative sample.
    Robinson J; Sareen J; Cox BJ; Bolton J
    J Anxiety Disord; 2009 Jan; 23(1):38-45. PubMed ID: 18571370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbid substance and mental disorders among rural Americans: results from the National Comorbidity Survey.
    Simmons LA; Havens JR
    J Affect Disord; 2007 Apr; 99(1-3):265-71. PubMed ID: 16978706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis].
    Potvin S; Stip E; Roy JY
    Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How does one manage a patient with an anxiety disorder who has been self-medicating with psychotropic drugs?
    Wilson A
    J Psychiatry Neurosci; 1999 Nov; 24(5):483. PubMed ID: 11499430
    [No Abstract]   [Full Text] [Related]  

  • 9. Epidemiology, risk factors, and psychopharmacological management of suicidal behavior in borderline personality disorder.
    Kolla NJ; Eisenberg H; Links PS
    Arch Suicide Res; 2008; 12(1):1-19. PubMed ID: 18240030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spectrum of substance abuse in bipolar disorder: reasons for use, sensation seeking and substance sensitivity.
    Bizzarri JV; Sbrana A; Rucci P; Ravani L; Massei GJ; Gonnelli C; Spagnolli S; Doria MR; Raimondi F; Endicott J; Dell'Osso L; Cassano GB
    Bipolar Disord; 2007 May; 9(3):213-20. PubMed ID: 17430295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Panic disorder and addiction: the clinical issues of comorbidity.
    DuPont RL
    Bull Menninger Clin; 1997; 61(2 Suppl A):A54-65. PubMed ID: 9149465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comorbidity of psychiatric disorders and posttraumatic stress disorder.
    Brady KT; Killeen TK; Brewerton T; Lucerini S
    J Clin Psychiatry; 2000; 61 Suppl 7():22-32. PubMed ID: 10795606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Frequency of smoking, drinking, and substance use and their relationship to psychiatric comorbidity in depressed child and adolescent population].
    Kiss E; Pikó B; Vetró A
    Psychiatr Hung; 2006; 21(5):371-8. PubMed ID: 17297199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C; Polard E; Mauduit N; Allain H
    Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of affective comorbidity in a clinical population of dually diagnosed adolescent substance abusers.
    Bukstein OG; Glancy LJ; Kaminer Y
    J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1041-5. PubMed ID: 1429402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opportunities for treatment of psychoactive substance use disorders with serotonergic medications.
    Sellers EM; Higgins GA; Tomkins DM; Romach MK; Toneatto T
    J Clin Psychiatry; 1991 Dec; 52 Suppl():49-54. PubMed ID: 1752860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Severe depression and addictions].
    Cottencin O
    Encephale; 2009 Dec; 35 Suppl 7():S264-8. PubMed ID: 20141784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiety and addiction: a clinical perspective on comorbidity.
    DuPont RL
    Bull Menninger Clin; 1995; 59(2 Suppl A):A53-72. PubMed ID: 7795572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.